




J. Afr. Ass. Physiol. Sci. 2 (2): 149-158 (2014) 
 
Journal of African Association of Physiological Sciences 






 Research Article 
Combined effects of metformin and honey on lipid metabolism in 
diet-induced hyperlipidemic rats 
 
Elsie O. Adewoye* and A. E Bamisile 




Metformin, Honey, Lipid 





























The study was designed to evaluate the combined effect of metformin and honey treatments on 
lipid metabolism in diet-induced hyperlipidemic rats. Eighty-five male Wistar rats (80-100g): 
twenty normal and sixty-five hyperlipidemic rats were used. Sixty-five rats were fed with high 
fat diet for 30 days to induce hyperlipidemia. Five rats each from control and hyperlipidemic  
were randomly selected to evaluate fasting blood glucose (FBG) level and hyperlipidemic 
state. Fifteen normal rats (control) formed Group 1(received 0.3ml/100g b.w distilled water) 
and the hyperlipidemic rats were divided into 4 groups of fifteen rats. Group 2 (hyperlipidemic 
control), Group 3 (hyperlipidemic plus metformin-100mg/kg), Group 4 (hyperlipidemic plus 
honey-1ml/100g); Group 5 (hyperlipidemic plus metformin-100mg/kg) and honey(1ml/100g). 
All treatments were administered orally, once daily for 28 days and animals were weighed 
weekly throughout the study. Blood was obtained from 5 rats in each group weekly post 
treatments through retro-orbital plexus, FBG was assessed using glucometer(Acucheck) and 
serum from remaining blood sample was used for assessing total cholesterol (TC), 
triglycerides (TG), high density lipoprotein (HDL), spectrophotometrically using Agape 
Biochemical kits. Low density lipoprotein (LDL), Very low density lipoprotein (VLDL), 
atherogenic index and HDL/LDL ratio were mathematically calculated. Histology of the liver 
was done using H&E stain. The FBG was significantly reduced in all treatment groups (3, 4 
and 5) compared with Groups 1 and 2 (the controls). Group 5 animals showed significant 
reduction in TC, TG, LDL, VLDL and significant increase in HDL level by day 28 of 
treatment compared with controls. Histopathological results showed severe diffuse fatty 
infiltration of the hepatocytes and extensive periportal vacuolar degeneration of hepatocytes at 
day 28 in hyperlipidemic group while group 5 showed very mild diffuse periportal cellular 
infiltration of the hepatic parenchyma with no visible lesion. It was concluded that the 
combination of both metformin and honey treatments significantly reduced blood glucose 
level, serum total cholesterol, triglycerides, low density lipoprotein and fatty infiltration of 
hepatic parenchyma and increase high density lipoprotein level which was not achieved with 
administration of either metformin or honey alone in hyperlipidemic rats. 
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INTRODUCTION 
Cardiovascular disease remains the chief cause of 
death in most countries of the world, and 
atherosclerosis, the principal cause of myocardial 
infarction, accounts for the majority of these deaths 
(Yokozawa et al, 2006). Hyperlipidemia is 
 
characterized by elevated cholesterol and fatty 
substances in the blood, and this is one important factor 
associated with atherosclerosis, a major risk factor for 
Coronary heart disease (Lecerf & de Lorgeril 2011). 
Hyperlipidemia is therefore a cause of concern for 
health professionals, being one of the major risk factors 
for the development of cardiovascular diseases (Gomes 
et al, 1998; Gerhardt and Gallo, 2008). Hyperlipidemia 
induces vascular functional changes that may leads to 
local ischemia and vascular remodeling (Bentley et al, 
2002). Clinical trials show that lowering lipid level 
reduces the morbidity and mortality associated with 














cardiovascular complication, thus regulating the serum 
cholesterol level helps to prevent atherosclerosis 
(Amundsen et al, 2002). 
Metformin is an oral anti diabetic drug belonging to 
the class of biguanide. It is a drug of choice for the 
treatment of type 2 diabetes, in particular, in 
overweight and obese people characterized by 
hypercholesterolemia-inducing insulin resistance (Lord 
et al, 2003). Elevated levels of cholesterol and free 
fatty acid commonly seen in hyperlipidemic patients 
usually result into the development of insulin resistance 
(Clore, 1991). Insulin resistance with the ensuing 
hyperinsulinemia is associated with 
hypertriglyceridemia and low serum high-density 
lipoprotein (HDL) cholesterol concentrations. 
 
The fact that antioxidants have several preventive 
effects against different diseases, such as cancer, 
coronary diseases, inflammatory disorders, 
neurological degeneration, and aging, led to the search 
for food rich in antioxidants. Available evidence 
indicates that individuals with chronic or degenerative 
diseases are more susceptible to oxidative stress and 
damage because they have elevated levels of oxidants 
and/or reduced antioxidants (Kandebach, 2009, Ienco et 
al, 2011).  
Honey, a natural product formed from flower nectar 
by honeybees, has been reported to be beneficial in 
management of altered lipid states (Nemoseck et al, 
2011). Honey is a commonly consumed product in 
most households (Bogdanov, 2008). Administration of 
honey alone or in combination with conventional 
therapy could therefore produce better therapeutic 
benefits in the management of chronic heart diseases, 
atherosclerosis and hyperlipidemia which are 
commonly associated with oxidative stress. In view of 
the dearth of information on the combined use of 
metformin and honey in hyperlipidemic state, this study 
was designed to evaluate the combined effect of 
metformin and honey treatments on lipid metabolism in 
diet-induced hyperlipidemic rats.  
 
Materials and Methods 
A total of eighty five male Wister rats were used in 
the study. Hyperlipidemia was induced in sixty-five 
(65) rats (80-100g) with continuous high fat diet for 
30days (Sheyla et al, 2005; Vikram and Arindum, 
2011; Nyangono et al, 2012) with free access to water 
while 20 normal rats were fed normal rat chow and 
watered ad libitum. The high-fat diet was composed 
based on the method of Blank et al (1963), adapted by 
Sheyla et al, (2005) and Dhaval et al, (2011) with little 
modification. The composition of this diet is shown in 
Table 1. Proximate analysis of the experimental diet 
shows it contained Gross Energy of 3,967kcal/kg, crude 
protein of 6.47g%, 16.79g% of fat, 3.83g% crude fibre 
and ash 7.03g%.  After 30days of feeding the animals 
with high fat diet, five rats each from control and 
hyperlipidemic groups were randomly selected and 
sacrificed for assessment of Fasting Blood Glucose and 
Hyperlipidemic state. 
Fifteen normal rats, fed normal rat chow with free 
access to water served as control. In addition, it was 
daily given 0.3ml distilled water orally. The remaining 
hyperlipidemic rats (60) were classified into group 2 
(hyperlipidemia control), group 3 - (hyperlipidemia 
treated with metformin (100mg/kg b.w) (Young et al, 
2008), Group 4 (hyperlipidemia treated with honey 
(1ml/100g b.w) (Asiyah et al, 2011). Group 5 
(hyperlipidemia treated with both metformin 
(100mg/kg b.w) and honey (1ml/100g b.w). Feeding 
with high fat diet was continued throughout the 
experiment. 
All treatments were administered orally using 
orogastric tube once daily for 28 days. The weights of 
all animals were monitored weekly throughout the 
experiment. Blood samples were obtained weekly, post 
treatments through the retro-orbital sinus. The FBG 
was assessed using glucometer and remaining blood 
was allowed to coagulate. The serum obtained was 
centrifuged at 3000 rpm for 15mins with a bench top 
centrifuge to obtain clear serum and used for assessing 
total cholesterol (TC), triglycerides (TG), high density 
lipoprotein (HDL) were estimated 
spectrophotometrically using Agape Biochemical kits 
(Young 2001, Akpanabiatu et al, 2005). Low density 
lipoprotein (LDL), Very low density lipoprotein 
(VLDL), atherogenic index and HDL/LDL – 
Cholesterol ratio were mathematically calculated 
(Friedewald, 1972). Animals were sacrificed by 
cervical dislocation to harvest the livers for histological 
examinations using H&E staining techniques 
(Banchroft et al, 1996).  
 
Statistical analysis: 
Data obtained were expressed as Mean ± SEM and 
analyzed using ANOVA. Statistical level of  
 











Table 1:  Composition of experimental diet 
INGREDIENT           Kg 
Maize          40.00 
Groundnut cake         13.60 
Cornstarch         14.00 
Glucose          21.00 
Palm Kernel Oil         10.00 
Bone meal           1.00 
Lysine            0.10 
Methionine            0.10 
Salt            0.20 
 
 
significance was chosen at p < 0.05 and p< 0.01 (Steel 
and Torrie, 1980). 
 
Results 
The composition of this diet is shown in Table 1. 
Proximate analysis of the experimental diet shows it 
contained Gross Energy of 3,967kcal/kg, crude protein 
of 6.47g%, 16.79g% of fat, 3.83g% crude fibre and ash 
7.03g%. Animals were fed for 30days to induce 
hyperlipidemia and their weights monitored weekly 
(Sheyla et al, 2005; Vikram and Arindum, 2011; 
Nyangono et al, 2012).  
 
Table 2: Effects of metformin and honey on body weight (g) in diet-induced hyperlipidemic rats 
 
Body weight 
      (grams) 
Treatment 
days post 
hyperlipidemia   
   
Group 1 
(Control) 













           
69.30±3.80 






             
69.20±1.49 






             
66.60±2.84 






             
66.20±4.62 
       70.80±5.83               
52.40±2.84* 
 
*Significantly different from control, p< 0.05 
 
 












hyperlipidemia   
   
Group 1 
(Control) 
               
Group 2 
(Metformin) 
        
Group 3 
(Honey) 
           





117.33±6.02        
             
117.33±6.02 
        
117.33±6.02 






             
103.60±9.59 
       
104.00±6.63 





             
100.00±3.56* 
         
93.60±6.56* 






               
97.20±1.53* 
         
92.80±6.44* 
             
71.00±1.70** 
 
Significantly different from control, *p< 0.05; **p<0.0 
 
  











Table 4: Effects of metformin and honey on lipid profiles in diet-induced hyperlipidemic rats 
Parameter Treatment 
days post 
hyperlipidemia   
















       
171.28±11.10 
       
171.28±11.10 






           
132.40±7.03 
       
169.02±11.80 






           
136.49±12.60 
       
148.35±13.60 






           
112.62±9.99** 
       
131.39±15.60 
           
111.99±17.40* 
Triglycerides 





           
117.90±17.20 







           
121.88±6.28 







            
97.99±4.29* 
     
110.53±12.78* 






            
83.68±7.54* 
      
79.41±4.07* 
           
66.11±1.61** 
HDL-CHOL 
       (mg/dl 
 
0 
    
33.03±4.40 
             
33.03±4.40 
       
 33.03±4.40 




    
26.04±3.48 
             
33.28±2.61 
        
28.41±4.38 




    
24.59±2.47 
             
34.94±4.55 





    
20.34±2.80 
            
38.45±2.67** 
       37.26±5.19*           
56.35±6.67** 
LDL-CHOL 
       (mg/dl) 
 
0 
    
114.67±9.49 
            
114.67±9.49 
       114.67±9.49 114.67±9.49 
 
7 
    
103.11±19.42 
             
74.74±8.79 





    
100.69±24.55 
             
82.15±16.93 




    
123.98±19.59 
              
57.43± 8.87* 
        78.25±16.44           
42.42±17.92* 
VLDL-CHOL 
          (mg/dl) 
 
0 
     
23.58±3.43 
            
23.58±3.43 




     
28.47±1.89 
            
24.38±1.26 




     
37.89±2.95 
            
19.39±0.89* 





     
38.80±4.42 
            
16.74±1.51* 
         
15.88±0.81* 
          
13.22±0.32** 
 
Significantly different from control, *p< 0.05; **p<0.01 













Fig. 1: Histopathological results of diet-induced hyperlipidemic rats 
1A. Photomicrograph of the Liver histology (H & E Staining) of hyperlipidemic rats after being fed with high  
                 calorie diet for 30 days, showing severe portal congestion and diffuse  fatty infiltration of the hepatic  
                 parenchyma (white arrows) (x 200). 
1B. Photomicrograph of the Liver histology (H & E Staining) of rat after 14days administration of 100mg/kg  
                 body weight of Metformin, showing diffuse mild fatty infiltration (FI) of the hepatic parenchyma, the  
                 congested Central Vein (CV) is also visible (x100) 
1C. Photomicrograph of the Liver histology (Hematoxylin & Eosin Staining) of Honey treated hyperlipidemic  
                 rat at 14th day of 1ml/100g  body weight of honey administration, showing severe diffused fatty    
                 infiltration of the hepatic parenchyma and vacuolar degeneration (white arrows). The Portal Canal  
                 (thick white arrow) is also visible (x100).  
1D. Photomicrograph of the Liver Histology (Hematoxylin & Eosin Staining) of rat treated with Metformin in  
                 adjunct with Honey for 14days, showing mild portal congestion and periportal cellular infiltration by   






















Table 5: Effects of metformin and honey on lipid indices in diet- induced hyperlipidemic rats 
Parameters Treatment 
days post 
hyperlipidemia   









Atherogenic           
         index 
 
0 
     
27.47±4.05 
             
27.47±4.05 
         
27.47±4.05 




     
33.05±1.80 
             
26.74±1.29 
         
31.81±2.56 




     
42.22±1.93 
             
22.15±1.12* 





     
45.66±4.24 
             
18.21±1.47* 
         
18.27±0.99* 







     
0.31±0.05 
              
0.31±0.05 




     
0.34±0.14 
              
0.49±0.09 




     
0.33±0.10 
              
0.66±0.32 




     
0.20±0.07 
              
0.73±0.09* 
0.63±0.20 2.87±0.40* 
Significantly different from control, *p< 0.05; **p<0.01 
 
In table 2, hyperlipidemic control group showed 
significant (p< 0.05) increase in body weight compared 
to normal control, while hyperlipidemic Metformin and 
Honey treated group showed significant (p< 0.05) 
decrease in body weight between the 14th and the 28th 
days of treatment, compared to hyperlipidemic control 
and normal. 
 Figure 1 shows significant (p<0.05) decrease in 
fasting blood glucose levels in Metformin alone and 
Honey alone treated groups, while there was significant 
decrease (<0.01) in the Metformin and Honey 
combined treated group. 
Figure 2 shows significant decrease (P<0.01) in serum 
total cholesterol in Group 3 and (P<0.05) decrease in 
group 5 compared to group 2, the hyperlipidemic 
untreated. Figure 3 shows significant (P<0.05) decrease 
in serum triglycerides in groups 3&4 and (P<0.01) 
decrease in group 5 when compared to group 2, the  
hyperlipidemic untreated, but similar to group1, the 
normal control.  
Figure 4 shows significant increase (P<0.01) in 
serum HDL-Cholesterol in groups 3&5 when compared 
to group 2. While group 4 showed significant (P<0.05) 
increase in serum Hdl when compared to group 2, more 
than the normal control group. 
Figure 5 shows significant (P<0.01) reduction in 
VLDL-C in group 5 compared to group 2, and this 
value is comparable to normal. 
Table 3 shows significant (P<0.05) decrease in 
LDL-Cholesterol in groups 3&5 compared to group 2, 
and these values are comparable to the normal group. 
Table 4 shows significant (P<0.01) reduction in 
Atherogenic index in group 5 compared to group 2. 
Table 5 shows significant (P<0.05) increase in 
HDL/LDL- ratio in groups 3&5, compared to group 
1&2.   
 












2A. Photomicrograph of the Liver Histology (H & E Staining) of rat in the negative control group, without  
                 any form of treatment after 28days, showing very severe diffuse fatty infiltration of the  hepatocytes  
                 (thick white arrows) and extensive periportal vacuolar degeneration of hepatocytes (white arrows).    
                 Severely congested Central vein is also visible (CV) (x 400). 
2B. Photomicrograph of the Liver Histology (H & E Staining) of rat treated with 100mg/kg body weight  
                 Metformin for 28days, showing mild portal congestion (white arrows) with no visible lesion (x 100). 
2C. Photomicrograph of the Liver Histology (H & E Staining) of rat treated with 1ml/100g body weight  
                 Honey for 28days, showing mild diffused periportal fatty infiltration (white arrows) of the hepatic  
                 parenchyma and severe congestion of the Centre vein (CV) .The portal canal (thick white arrow) is  
                 also visible (x 100). 
2D. Photomicrograph of the Liver Histology (H & E Staining) of rat treated with 100mg/kg body weight of  
                 Metformin in adjunct with 1ml/100g of Honey for 28days, showing very mild diffuse periportal cellular    




Plate 1 shows the photomicrographs of the liver 
histology on day7 post-treatments. Severe portal 
congestion and diffuse fatty infiltration of hepatic 
parenchyma were observed in hyperlipidemic untreated 
group, compared to control which has normal 
hepatocyte architecture, while Metformin and Honey 
combined treated group shows mild diffuse fatty 
infiltration of the hepatic parenchyma. 
Plate 2 shows the photomicrographs of the liver 
histology on day14 post-treatments. Severe periportal 
vacuolar degeneration was seen in the hyperlipidemic 
untreated rat, whereas mild fatty infiltration and 
periportal cellular infiltration by mononuclear cells 
were seen in the Metformin and Metformin with Honey 
combined treated group. 
Plate 3 shows the photomicrographs of the liver 
histology on day28 post-treatments. The fatty 
infiltration of the hepatocytes seen in the 
hyperlipidemic untreated rat was ameliorated in 
hyperlipidemic rats treated individually with metformin 










and honey and almost completely ameliorated with 




Increased body weight observed in the hyperlipidemic 
group could be attributed to increased fat deposition 
from the fat-rich diet (Zulet and Martinez, 1995, Woo 
and Henry, 1996, Ramachandran et al, 2003).  Reduced 
body weight observed in the treated groups compared 
with controls showed that treatment of hyperlipidemic 
rats with metformin or honey and combination of both 
reduced weight gain. These observations revealed that 
the treatment controlled excessive weight gain in 
dyslipidemia and are in agreement with the use of 
various supplements for weight control (Millgate and 
Robert, 1995, Cho et al, 2005).  
The elevated level of blood glucose observed in the 
hyperlipidemic untreated (negative control) may be due 
to increased insulin resistance which could have 
developed as a result of increased ingestion of fatty 
food substances by the experimental rats. Previous 
reports have shown that elevated levels of cholesterol 
and free fatty acid commonly seen in hyperlipidemic 
patients usually result in development of insulin 
resistance (Clore, 1991, Wellen et al, 2005). One of the 
mechanisms by which hyperlipidemia results into 
insulin resistance may be through the action of the 
saturated fatty acids that impairs the transduction of the 
insulin signaling pathway hence affecting the 
metabolism of glucose by insulin, resulting largely in 
increased resistance (Wellen et al, 2005).  
The hypoglycemic activities of metformin could be 
a result of its ability to reduce free fatty acid oxidation. 
Increased fatty acid oxidation inhibits key enzymes of 
the glycolytic pathway by accumulation of by-products 
of free fatty acid oxidation (Hundal et al 1992). Results 
indicate that combination of metformin with honey 
further reduced the elevated blood glucose level not 
achieved with administration of either metformin or 
honey alone.   
Studies have been done to evaluate the 
hypercholesterolemic effect of high cholesterol and 
high-fat diet in experimental animals (Edijala et al, 
2005; Fki et al, 2005; Hartvigsen et al, 2007; 
Gopichanchinta et al, 2009; Nyangono et al, 2012). The 
increased blood levels of total cholesterol, Low Density 
Lipoprotein Cholesterol (LDL-C), Very Low Density 
Lipoprotein Cholesterol (VLDL-C) and triglyceride-
carrying lipoproteins as well as lowered levels of High 
Density Lipoprotein Cholesterol (HDLC) has been 
identified in development of hyperlipidemia (Ross, 
1999). This study showed that adjunct use of metformin 
with honey lowers the risks of Coronary Heart Disease 
(CHD) development by reducing the elevated levels of 
serum total cholesterol, triglycerides and LDL – 
Cholesterol level while it increases HDL-Cholesterol 
level. The positive effect of the combined therapy was 
confirmed by the increased atherogenic index (Hawkins 
and Ounpuu, 2004). Histopathological studies of the 
liver confirmed the biochemical results obtained 
(Figures 2,3&4).   
 In conclusion, this study showed that 
combination of metformin and honey treatments reduce 
elevated blood glucose level, serum total cholesterol, 
triglycerides, Low Density Lipoprotein  and fatty 
infiltration of hepatic parenchyma, while it increased 
the High Density  Lipoprotein level not achieved with 
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